InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
4
T+90 胜率
0%
T+90 平均收益
-50.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Nagendran Sukumar, 董事. Director active across 2 companies, notably Taysha Gene Therapies, Inc.. Cumulatively, 12 filings have been published. Split: 2 buys · 4 sells. Total volume traded: €2.4m. History available since 2 February 2022. The latest transaction was filed on 10 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nagendran Sukumar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
200,000 股@ US$6.240.073% mcap63.2% 占其流量Common StockSEC:0001665124-26-000013:0
19,021 股@ US$1.710.0019% mcap3.0% 占其流量Common StockSEC:0001665124-26-000011:0
200,000 股@ US$4.460.051% mcap81.5% 占其流量Common StockSEC:0001665124-26-000011:1
89,132 股@ US$4.7520.9% 占其流量Common StockSEC:0001665124-26-000008:0
111,324 股@ US$0.69893.9% 占其流量Common StockSEC:0001665124-26-000002:0
70,172 股@ US$0.698920.4% 占其流量Common StockSEC:0001665124-25-000003:0
41,150 股@ US$0.698914.9% 占其流量Common StockSEC:0001415889-25-024369:0
57,054 股@ US$2.85100.0% 占其流量Common StockSEC:0001415889-25-022750:0
324,500 股0Common StockSEC:0001415889-25-000597:0
863,617 股0Common StockSEC:0001209191-24-000809:0
5,000 股@ US$0.682.2% 占其流量Common StockSEC:0001209191-23-030661:0
标准退出：2023年8月14日 (T+90)
10,000 股@ US$8.018.2% 占其流量Common StockSEC:0001209191-22-006652:0
标准退出：2022年5月3日 (T+90)
12 条申报中的 12 条
About Nagendran Sukumar
Nagendran Sukumar is an Administrateur and President and Head of R&D at Taysha Gene Therapies, Inc. He has 12 filings in total. Across the 12 most recent filings we hold, the modal transaction nature is sell, with buys of 74178 euros and sells of 2353289 euros between 2022-02-03 and 2026-07-10.
